Mucormycosis - an opportunistic disease in the COVID-19 (SARS-CoV-2) pandemic: Lessons from shreds of evidence

  • Bedanta Roy Quest International University (QIU), No. 227, Plaza Teh Teng Seng (Level 2), Jalan Raja Permaisuri Bainun, 30250 Ipoh, Perak Darul Ridzuan, Malaysia http://orcid.org/0000-0003-2750-4949
  • Sumitabha Ghosh Quest International University (QIU), No. 227, Plaza Teh Teng Seng (Level 2), Jalan Raja Permaisuri Bainun, 30250 Ipoh, Perak Darul Ridzuan, Malaysia https://orcid.org/0000-0002-4108-4939
DOI: https://doi.org/10.5281/zenodo.5201461
Keywords: COVID-19, diabetes, infection, mucormycosis, steroids

Abstract

No abstract available

Author Biographies

Bedanta Roy, Quest International University (QIU), No. 227, Plaza Teh Teng Seng (Level 2), Jalan Raja Permaisuri Bainun, 30250 Ipoh, Perak Darul Ridzuan, Malaysia

Senior Lecturer, Department of Physiology, Faculty of Medicine

Sumitabha Ghosh, Quest International University (QIU), No. 227, Plaza Teh Teng Seng (Level 2), Jalan Raja Permaisuri Bainun, 30250 Ipoh, Perak Darul Ridzuan, Malaysia

Professor and Head, Department of Physiology, Faculty of Medicine

Published
2021-07-18
How to Cite
Roy, B., & Ghosh, S. (2021). Mucormycosis - an opportunistic disease in the COVID-19 (SARS-CoV-2) pandemic: Lessons from shreds of evidence. Quest International Journal of Medical and Health Sciences, 4(1), 1-3. https://doi.org/10.5281/zenodo.5201461
Issue
Vol. 4 No. 1 (2021): QIJMHS
Section
Editorial

Copyright (c) 2021 Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.